Taro Pharmaceutical Industries Ltd - Company Profile
Powered by
All the data and insights you need on Taro Pharmaceutical Industries Ltd in one report.
- Save hours of research time and resources with
our up-to-date Taro Pharmaceutical Industries Ltd Strategy Report
- Understand Taro Pharmaceutical Industries Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
The following section provides information on Taro Pharmaceutical Industries Ltd’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Taro Pharmaceutical Industries Ltd's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Dilip Shanghvi
Chairman Executive BoardMr. Dilip Shanghvi has been the Chairman of the company since 2013. Mr. Shanghvi also serves as the Chairman and Managing Director of Sun Pharma Advanced Research Company Ltd., and Chairman of the Shantilal Shanghvi Foundation.
Uday Baldota
Director; Chief Executive Officer Executive BoardMr. Uday Baldota has been the Chief Executive Officer and Director of the company since 2017. Prior to this, he served as the Executive Vice President and Chief Financial Officer of Sun Pharmaceutical Industries Ltd. Mr. Uday also serves on the board of directors of the Association for Accessible Medicines.
William J. Coote
Vice President; Chief Accounting Officer; Chief Financial Officer Senior ManagementMr. William J. Coote has been the Vice President, Chief Financial Officer and Chief Accounting Officer of the company since 2021. He has served in finance positions of various companies such as Bowne & Co Inc, Prudential Realty, Merrill Lynch, and Ernst & Young.
Abhay Gandhi
Vice Chairman Executive BoardVikash Agarwal
Head - Business Development; Vice President Senior ManagementHave you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer